Delivery Order SPE2DB20D3101-SPE2DB22FJ5Q9
- Not listed
- This federal contract award is for the delivery of Methylphenidate ER 27 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 25, 2022, with a ceiling value of $1,053.45. The contract has a firm fixed-price pricing type and an ultimate completion date of February 28, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is a for-profit organization registered in the System...
- This federal contract award is for the delivery of Methylphenidate ER 18 mg tablets in 100-count packages to the Defense Logistics Agency (DLA), a defense agency. The $3,442.39 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 28, 2025, with an ultimate completion date of May 29, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
- This federal contract award is for the delivery of Methylphenidate ER 18 mg tablets in quantities of 100s to the Defense Logistics Agency (DLA). The $3,188.30 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. This order is a child of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award is for the delivery of Methylphenidate ER 54 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $2,189.64, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a performance period ending on February 29, 2024. The award is not designated under any set-aside program, indicating it was competitively awarded. Amerisourcebergen...
- This federal contract award is for the delivery of Methylphenidate ER 36 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,878.17 firm fixed price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
- This federal contract award is for the delivery of Methylphenidate ER 54 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $3,094.85 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
- This federal contract award is for the delivery of Methylphenidate ER 36 mg tablets, a prescription medication, to the Defense Logistics Agency (DLA). The $1,334.73 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 6, 2025, with a completion date of May 7, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Methylphenidate ER 27 mg tablets, with a total ceiling value of $1,195.52. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of February 10, 2025. This contract award is not designated as a set-aside. AmerisourceBergen Drug...
- This federal contract award is for the delivery of methylphenidate ER tablets, 54mg, to the Defense Logistics Agency (DLA) Troop Support Medical. The $10,900.39 delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is a firm fixed-price, delivery order type with a completion date of June 14, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
- This federal contract award is for the delivery of Methylphenidate ER 36 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $5,638.94, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is January 4, 2024. The contract is not designated with any set-aside requirements, indicating it was awarded through full and open competition....
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FJ5Q9Delivery Order
This federal contract award is for the delivery of Methylphenidate ER 27 mg tablets to the Defense Logistics Agency (DLA). The $3,845.37 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on April 22, 2022, with a completion date of April 25, 2022. The contract is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies for military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This delivery order did not have a set-aside designation, indicating open competition. Amerisourcebergen, as a major pharmaceutical distributor and healthcare solutions provider, plays a critical role in supplying essential medical products to federal government agencies, including the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 4/22/22 |